Wednesday, Nov 26, 2014Wednesday, Nov 26, 2014
News
 

New drugs propel Bayer Healthcare's growth in Asia-Pacific

Published on Mar 21, 2014 3:34 PM
 

Bayer Healthcare - which has its Asia-Pacific headquaters in Singapore - is the region's fastest-growing drug company, new figures reveal.

Global health information service IMS Health found regional sales of its drugs grew by 15 per cent to $5.3 billion last year.

The German pharmaceutical giant is ranked ninth in the region in terms of sales and 14th worldwide with sales of $22 billion.

Bayer has launched several new drugs including Eylea, which fights macular degeneration - a major cause of blindness among the elderly. It went on sale in Singapore at the end of last year and was Bayer's best-ever drug launch in Australia, with sales topping $108 million within seven months of the product entering the market.

 
If you are not a subscriber, you can get instant, unlimited access here